Table 2.
Comparison of clinical data between the MACE group and non-MACE group (n, ± s, %).
| Item | Non-MACE group (n = 37) | MACE group (n = 13) | χ 2/t value | P-Value |
|---|---|---|---|---|
| Age (years) | 73.59 ± 2.51 | 75.77 ± 3.54 | 2.412 | 0.020 |
| Male | 22 (59.46%) | 8 (61.54%) | 0.017 | 0.895 |
| History of coronary heart disease | 21 (56.76%) | 7 (53.85%) | 0.033 | 0.856 |
| History of diabetes | 11 (29.73%) | 4 (30.77%) | 0.005 | 0.944 |
| History of hypertension | 22 (59.46%) | 9 (69.23%) | 0.390 | 0.532 |
| WBC (×109/L) | 6.12 ± 1.13 | 7.11 ± 1.66 | 2.393 | 0.021 |
| NEU (×109/L) | 4.65 ± 1.02 | 5.55 ± 1.48 | 2.422 | 0.019 |
| LYM (×109/L) | 1.61 ± 0.21 | 1.16 ± 0.19 | 6.802 | <0.001 |
| PLT (×109/L) | 180.51 ± 33.03 | 209.23 ± 47.98 | 2.386 | 0.021 |
| Blood glucose (mmol/L) | 5.92 ± 1.22 | 6.99 ± 1.78 | 2.402 | 0.020 |
| NLR | 2.93 ± 0.64 | 5.12 ± 2.81 | 4.497 | <0.001 |
| NT-proBNP (pg/ml) | 3669.08 ± 349.48 | 3973.06 ± 507.73 | 2.386 | 0.021 |